Today's Rundown MD Anderson's Hahn picked as next FDA commissioner Halozyme kills pipeline, cuts 55% of jobs as lead cancer med flops in phase 3 FDA tells Aveo no, again, for tivozanib as biotech tries to find yet another path forward [Sponsored] Flip the Funnel: Rethinking Patient Recruitment and Enrollment Strategies Small Alzheimer's hopeful biotech nabs $15M series B for metabolic drug approach U.K. researchers developing 'smell-powered' diagnostic to sniff out diseases The 2019 FiercePharma Marketing Awards Featured Story | | | Friday, November 1, 2019 It’s official: President Donald Trump has nominated Stephen Hahn as the next commissioner of the FDA. |
|
|---|
|
Top Stories Monday, November 4, 2019 Until today, Halozyme worked under a two-pillar strategy, with licensing dollars from its Enhanze drug delivery technology bankrolling its cancer pipeline. Now, with the failure of its lead program in pancreatic cancer, the company is pulling the plug on drug development to focus solely on Enhanze and cutting 55% of its staff in the process. Monday, November 4, 2019 In a "Groundhog Day" scenario, the FDA has once more slapped down Aveo Oncology’s attempt to get its ill-fated cancer drug on the U.S. market. Monday, November 4, 2019 No matter how successful advertising campaigns are, all that really matters is how many referrals ultimately participate in the trial. It’s time to flip the funnel and focus on converting recruits into enrollees. Monday, November 4, 2019 A small private biotech has raised a modest series B round as it continues to test its idea that the memory-wasting disease can be beaten back by focusing on fat and sugar metabolism in the brain. Monday, November 4, 2019 Researchers at the University of Bristol in England are developing a device that mimics the sensitive sense of smell possessed by dogs and other mammals and is capable of sniffing out the faint chemical signatures of chronic diseases. Monday, November 4, 2019 Once considered neophytes in the hip and happening ad scene, pharma companies—some of them, at least—are breaking out with smart creative executions, innovative tools and tech-assisted novelties that go beyond standard pharma campaign fare. That’s evident in our first crop of award winners. Enrollment Showcase Resources Sponsored by: IBM Watson Health Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, we believe, is essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars. Learn more. Sponsored by: ON24 Discover solutions to the most common challenges faced by medical device companies. Sponsored by: Eli Lilly and Company in partnership with Xcenda Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system. Sponsored by: Clarivate Analytics 18 high-value new licensing deals worth in excess of $500 million took place during the second quarter of 2019 -Get the Q2 2019 Biopharma licensing report for full details and insights. Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BBK Worldwide Get the latest data on how people are using apps to manage their health, and learn how you can leverage it in the development of your next clinical trial app. Sponsored by: Blue Latitude Health Report: How to design digital services that deliver value and improve outcomes for patients, healthcare professionals and the healthcare systems they serve Sponsored by: Article Galaxy powered by Reprints Desk This white paper examines the skyrocketing cost of drug development and provides step-by-step guidance for executing a successful fail fast strategy. Sponsored by: Outer Edge Technology Companies that don’t have a cloud strategy are at a competitive disadvantage. Why? The cloud has a measurable impact on business. Sponsored by: Colorcon® Learn about how you better manage product authentication and battle drug counterfeiting with innovative solutions. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA A Rare Affair for Rare Diseases January 12, 2020 | San Francisco, CA | 